Loading chart...
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease, and Journavx, a non-opioid pain medication approved for the treatment of moderate-to-severe acute pain in adults. Additionally, Vertex is evaluating small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
| 24 jam | 5 days | 1 bulan | YTD | 1 tahun | Sepanjang waktu |
|---|---|---|---|---|---|
Turun 1.56 persen | Turun 1.39 persen | Turun 1.41 persen | Naik 12.02 persen | Naik 31.29 persen | Naik 3580.59 persen |
